Anoro Ellipta (umeclidinium and vilanterol inhalation powder), for Oral Inhalation

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   February 2016 ADVERSE REACTIONS Postmarketing Experience In addition to adverse reactions reported from clinical trials,...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts